Table of Contents
Thrombosis
Volume 2012, Article ID 245037, 7 pages
http://dx.doi.org/10.1155/2012/245037
Review Article

Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease

Shanghai Cardiovascular Institute and Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received 10 June 2011; Accepted 17 October 2011

Academic Editor: Christian Doutremepuich

Copyright © 2012 Yuxiang Dai and Junbo Ge. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Ian P Salt, and Timothy M Palmer, “Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation,” Expert Opinion on Investigational Drugs, vol. 21, no. 8, pp. 1155–1167, 2012. View at Publisher · View at Google Scholar
  • Sudhakar Koundinya Tippabhotla, Sandeep Yergude, Chaitanya Gadiko, Satyanarayana Thota, Sohel Md. Khan, Ramakrishna Battula, and Venkateswarlu Vobalaboina, “Steady state bioequivalence study of dipyridamole ER and acetyl salicylic acid 200 mg + 25  mg capsules in adult healthy male and female volunteers under fasting condition,” Clinical Research and Regulatory Affairs, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • Zhi-Jiang Wang, Jinhyuk Lee, Yue-Xiu Si, Sangho Oh, Jun-Mo Yang, Dong Shen, Guo-Ying Qian, and Shang-Jun Yin, “Toward the inhibitory effect of acetylsalicylic acid on tyrosinase: Integrating kinetics studies and computational simulations,” Process Biochemistry, vol. 48, no. 2, pp. 260–266, 2013. View at Publisher · View at Google Scholar
  • Lukasz J. Krzych, Malgorzata Lach, Sara Mustafa, Michal Joniec, Marcelina Niemiec, Maciej Wybraniec, Marek Cisowski, and Andrzej Bochenek, “Compliance with pharmacological treatment among patients after minimally invasive coronary bypass grafting,” Cardiology Journal, vol. 20, no. 6, pp. 648–654, 2013. View at Publisher · View at Google Scholar
  • Marcos Vinicius Ferreira Silva, Lauro Mello Vieira, Maria das Gracas Carvalho, and Luci Maria SantAna Dusse, “Platelet Antiaggregants in Primary and Secondary Prevention of Atherothrombotic Events,” Arquivos Brasileiros De Cardiologia, vol. 100, no. 6, pp. E78–E84, 2013. View at Publisher · View at Google Scholar
  • John J. McNeil, Livia Sanna, Adrienne O'Neil, Michael Berk, Olivia Dean, Hemmo Drexhage, Steven Moylan, Christopher G. Davey, and Michael Maes, “Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness,” Bmc Medicine, vol. 11, 2013. View at Publisher · View at Google Scholar
  • Paula Esquivias, Carmelo Cebrian, Antonio Morandeira, Sonia Santander, Javier Ortego, Maria Asuncion Garcia-Gonzalez, Angel Lanas, and Elena Piazuelo, “Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model,” Oncology Reports, vol. 31, no. 6, pp. 2785–2791, 2014. View at Publisher · View at Google Scholar
  • A.T. Cohen, S. Imfeld, J. Markham, and S. Granziera, “The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders,” Thrombosis Research, 2014. View at Publisher · View at Google Scholar
  • Haruko Yokoyama, Takashi Mastumura, Shinji Soeda, Yuji Suzuki, Masayuki Watanabe, Emiko Kashiwakura, Takayuki Saso, Noriyuki Ikeda, Kentaro Tokuoka, Yasuhisa Kitagawa, and Yasuhiko Yamada, “The evaluation method for antiplatelet effect of acetylsalicylic acid,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 39, no. 4, pp. 327–333, 2014. View at Publisher · View at Google Scholar
  • David A. Peura, and C. Mel Wilcox, “Aspirin and Proton Pump Inhibitor Combination Therapy for Prevention of Cardiovascular Disease and Barrett's Esophagus,” Postgraduate Medicine, vol. 126, no. 1, pp. 87–96, 2014. View at Publisher · View at Google Scholar
  • James Jeong, and Lillian Barra, “The Use of Anti-Platelet and/or Anticoagulant Agents in the Prevention of Large Vessel Vasculitis-Associated Ischemic Complications: A Meta-Analysis,” Open Journal of Rheumatology and Autoimmune Diseases, vol. 04, no. 02, pp. 114–123, 2014. View at Publisher · View at Google Scholar
  • Roy Altman, Bill Bosch, Kay Brune, Paola Patrignani, and Clarence Young, “Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology,” Drugs, 2015. View at Publisher · View at Google Scholar
  • Dean M. Cestari, Eric D. Gaier, Peggy Bouzika, Taylor S. Blachley, Lindsey B. De Lott, Joseph F. Rizzo, Janey L. Wiggs, Jae H. Kang, Louis R. Pasquale, and Joshua D. Stein, “Demographic, Systemic, and Ocular Factors Associated with Nonarteritic Anterior Ischemic Optic Neuropathy,” Ophthalmology, 2016. View at Publisher · View at Google Scholar
  • Niamh O’Kennedy, Daniel Raederstorff, and Asim K. Duttaroy, “Fruitflow®: the first European Food Safety Authority-approved natural cardio-protective functional ingredient,” European Journal of Nutrition, 2016. View at Publisher · View at Google Scholar
  • Dhruv Patel, Avik Roy, Madhuchhanda Kundu, Malabendu Jana, Chi-Hao Luan, Frank J. Gonzalez, and Kalipada Pahan, “Aspirin binds to PPARα to stimulate hippocampal plasticity and protect memory,” Proceedings of the National Academy of Sciences, pp. 201802021, 2018. View at Publisher · View at Google Scholar
  • Asim K. Duttaroy, “Human Blood Platelets and Their Role in the Development of Cardiovascular Disease,” Nutraceuticals and Human Blood Platelet Function, pp. 1–27, 2018. View at Publisher · View at Google Scholar